Similar articles

• [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].

  Harth Y, Hirshovitz B. Harth Y, et al. Harefuah. 1998 Apr 15;134(8):602-5, 672, 671. Harefuah. 1998. PMID: 10911421 Clinical Trial. Hebrew.
• Aminolevulinic acid photodynamic therapy for skin cancers.

  Blume JE, Oseroff AR. Blume JE, et al. Dermatol Clin. 2007 Jan;25(1):5-14. doi: 10.1016/j.det.2006.09.005. Dermatol Clin. 2007. PMID: 17126737 Review.
• Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme.

  de Haas ER, Sterenborg HJ, Neumann HA, Robinson DJ. de Haas ER, et al. Arch Dermatol. 2007 Feb;143(2):264-5. doi: 10.1001/archderm.143.2.264. Arch Dermatol. 2007. PMID: 17310011 Clinical Trial. No abstract available.
• Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.

  Souza CS, Felício LB, Bentley MV, Tedesco AC, Ferreira J, Kurachi C, Bagnato VS. Souza CS, et al. Br J Dermatol. 2005 Sep;153(3):672-4. doi: 10.1111/j.1365-2133.2005.06783.x. Br J Dermatol. 2005. PMID: 16120168 Review. No abstract available.
• [Retinoids in the treatment of epithelial skin tumors].

  Berretti B, Grupper C. Berretti B, et al. Ther Umsch. 1986 Sep;43(9):703-6. Ther Umsch. 1986. PMID: 3535155 Review. French. No abstract available.